Discovery of a 3-(4-Pyrimidinyl) Indazole (MLi-2), an Orally Available and Selective Leucine-Rich Repeat Kinase 2 (LRRK2) Inhibitor that Reduces Brain Kinase ActivityJack D. Scott, Michael W. Miller, John A. McCauley et al.|Journal of Medicinal Chemistry|2017Cited by 147
Seismic isolation enhancements for initial and advanced LIGOR. Abbott, W.D. Rankin, Anurag Ganguli et al.|Classical and Quantum Gravity|2004Cited by 68
Quiet Hydraulic Actuators for LIGOC. Hardham, M. E. Zucker, Claire Campbell et al.|IFAC Proceedings Volumes|2006Cited by 8